Document is current
Any future updates will be listed below
-
Authors
Ghochani, Ghazal
Aghajani, Amirhossein
Rajabi, Mohammad Taher
Zand, Amin
Yaseri, Mehdi
Rafizadeh, Seyed Mohsen
-
Funding
Funding for this research was provided by:
MasoonDarou Pharmaceutical Company, Tehran, Iran
- License Information
-
More Information
Article History
Received: 30 January 2025
Accepted: 3 April 2025
First Online: 23 May 2025
Declarations
:
: The authors declare that they have no conflict of interests.
: The study was approved by the ethics committee of Tehran University of Medical Sciences, Tehran, Iran (ethics code: IR.TUMS.FARABIH.REC.1402.015). The study was explained to eligible participants and written informed consents were obtained. The study was in accordance with Declaration of Helsinki and the national guidelines and regulations. The protocol of the study was registered in the Iranian clinical trials registry system (code: IRCT20230727058942N1) as of 12/18/2023 and is accessible at .
: Written informed consent was obtained from each study participant.
